vs
礼恩派(LEG)与Pediatrix Medical Group, Inc.(MD)财务数据对比。点击上方公司名可切换其他公司
礼恩派的季度营收约是Pediatrix Medical Group, Inc.的1.9倍($938.6M vs $493.8M),Pediatrix Medical Group, Inc.净利率更高(6.8% vs 2.7%,领先4.1%),Pediatrix Medical Group, Inc.同比增速更快(-1.7% vs -11.2%),过去两年Pediatrix Medical Group, Inc.的营收复合增速更高(-0.1% vs -7.5%)
礼恩派(Leggett & Platt)总部位于美国密苏里州迦太基,是一家多元化制造企业,成立于1883年。公司专注于设计生产各类工程组件及产品,广泛应用于家居与汽车领域。目前旗下设有15个业务单元,在全球18个国家拥有135座生产工厂,员工总数达2万名。
Pediatrix Medical Group是美国领先的专科医疗服务提供商,核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域,与美国各地医疗机构合作,为女性、新生儿及儿童提供循证专科医疗服务。
LEG vs MD — 直观对比
营收规模更大
LEG
是对方的1.9倍
$493.8M
营收增速更快
MD
高出9.4%
-11.2%
净利率更高
MD
高出4.1%
2.7%
两年增速更快
MD
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $938.6M | $493.8M |
| 净利润 | $25.1M | $33.7M |
| 毛利率 | 17.9% | — |
| 营业利润率 | 2.0% | 9.9% |
| 净利率 | 2.7% | 6.8% |
| 营收同比 | -11.2% | -1.7% |
| 净利润同比 | 76.8% | 10.5% |
| 每股收益(稀释后) | $0.18 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LEG
MD
| Q4 25 | $938.6M | $493.8M | ||
| Q3 25 | $1.0B | $492.9M | ||
| Q2 25 | $1.1B | $468.8M | ||
| Q1 25 | $1.0B | $458.4M | ||
| Q4 24 | $1.1B | $502.4M | ||
| Q3 24 | $1.1B | $511.2M | ||
| Q2 24 | $1.1B | $504.3M | ||
| Q1 24 | $1.1B | $495.1M |
净利润
LEG
MD
| Q4 25 | $25.1M | $33.7M | ||
| Q3 25 | $127.1M | $71.7M | ||
| Q2 25 | $52.5M | $39.3M | ||
| Q1 25 | $30.6M | $20.7M | ||
| Q4 24 | $14.2M | $30.5M | ||
| Q3 24 | $44.9M | $19.4M | ||
| Q2 24 | $-602.2M | $-153.0M | ||
| Q1 24 | $31.6M | $4.0M |
毛利率
LEG
MD
| Q4 25 | 17.9% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 18.2% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 17.0% | — |
营业利润率
LEG
MD
| Q4 25 | 2.0% | 9.9% | ||
| Q3 25 | 14.9% | 13.8% | ||
| Q2 25 | 6.8% | 12.8% | ||
| Q1 25 | 4.4% | 7.0% | ||
| Q4 24 | 2.4% | 7.8% | ||
| Q3 24 | 5.2% | 6.6% | ||
| Q2 24 | -56.2% | -31.3% | ||
| Q1 24 | 3.9% | 3.2% |
净利率
LEG
MD
| Q4 25 | 2.7% | 6.8% | ||
| Q3 25 | 12.3% | 14.5% | ||
| Q2 25 | 5.0% | 8.4% | ||
| Q1 25 | 3.0% | 4.5% | ||
| Q4 24 | 1.3% | 6.1% | ||
| Q3 24 | 4.1% | 3.8% | ||
| Q2 24 | -53.4% | -30.3% | ||
| Q1 24 | 2.9% | 0.8% |
每股收益(稀释后)
LEG
MD
| Q4 25 | $0.18 | $0.40 | ||
| Q3 25 | $0.91 | $0.84 | ||
| Q2 25 | $0.38 | $0.46 | ||
| Q1 25 | $0.22 | $0.24 | ||
| Q4 24 | $0.10 | $0.37 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $-4.39 | $-1.84 | ||
| Q1 24 | $0.23 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $587.4M | $375.2M |
| 总债务越低越好 | $1.5B | $570.5M |
| 股东权益账面价值 | $1.0B | $865.9M |
| 总资产 | $3.5B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.46× | 0.66× |
8季度趋势,按日历期对齐
现金及短期投资
LEG
MD
| Q4 25 | $587.4M | $375.2M | ||
| Q3 25 | $460.7M | $340.1M | ||
| Q2 25 | $368.8M | $224.7M | ||
| Q1 25 | $412.6M | $99.0M | ||
| Q4 24 | $350.2M | $229.9M | ||
| Q3 24 | $277.2M | $103.8M | ||
| Q2 24 | $307.0M | $19.4M | ||
| Q1 24 | $361.3M | $8.0M |
总债务
LEG
MD
| Q4 25 | $1.5B | $570.5M | ||
| Q3 25 | $1.5B | $577.2M | ||
| Q2 25 | $1.8B | $583.9M | ||
| Q1 25 | $1.9B | $590.5M | ||
| Q4 24 | $1.9B | $597.1M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.8B | — |
股东权益
LEG
MD
| Q4 25 | $1.0B | $865.9M | ||
| Q3 25 | $971.8M | $890.7M | ||
| Q2 25 | $855.0M | $833.8M | ||
| Q1 25 | $746.8M | $789.2M | ||
| Q4 24 | $689.4M | $764.9M | ||
| Q3 24 | $741.0M | $732.5M | ||
| Q2 24 | $667.6M | $706.5M | ||
| Q1 24 | $1.3B | $856.2M |
总资产
LEG
MD
| Q4 25 | $3.5B | $2.2B | ||
| Q3 25 | $3.5B | $2.2B | ||
| Q2 25 | $3.7B | $2.1B | ||
| Q1 25 | $3.7B | $2.0B | ||
| Q4 24 | $3.7B | $2.2B | ||
| Q3 24 | $3.8B | $2.1B | ||
| Q2 24 | $3.8B | $2.0B | ||
| Q1 24 | $4.6B | $2.2B |
负债/权益比
LEG
MD
| Q4 25 | 1.46× | 0.66× | ||
| Q3 25 | 1.54× | 0.65× | ||
| Q2 25 | 2.10× | 0.70× | ||
| Q1 25 | 2.59× | 0.75× | ||
| Q4 24 | 2.70× | 0.78× | ||
| Q3 24 | 2.13× | — | ||
| Q2 24 | 2.55× | — | ||
| Q1 24 | 1.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $121.5M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $101.9M | — |
| 自由现金流率自由现金流/营收 | 10.9% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 4.84× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $281.0M | — |
8季度趋势,按日历期对齐
经营现金流
LEG
MD
| Q4 25 | $121.5M | $114.1M | ||
| Q3 25 | $125.9M | $137.3M | ||
| Q2 25 | $84.0M | $137.2M | ||
| Q1 25 | $6.8M | $-117.5M | ||
| Q4 24 | $122.3M | $133.0M | ||
| Q3 24 | $95.5M | $91.8M | ||
| Q2 24 | $94.0M | $107.0M | ||
| Q1 24 | $-6.1M | $-125.2M |
自由现金流
LEG
MD
| Q4 25 | $101.9M | — | ||
| Q3 25 | $110.1M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $-6.5M | — | ||
| Q4 24 | $100.5M | — | ||
| Q3 24 | $77.1M | — | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | $-32.0M | — |
自由现金流率
LEG
MD
| Q4 25 | 10.9% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | -2.9% | — |
资本支出强度
LEG
MD
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.4% | — |
现金转化率
LEG
MD
| Q4 25 | 4.84× | 3.39× | ||
| Q3 25 | 0.99× | 1.91× | ||
| Q2 25 | 1.60× | 3.49× | ||
| Q1 25 | 0.22× | -5.66× | ||
| Q4 24 | 8.61× | 4.36× | ||
| Q3 24 | 2.13× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.19× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEG
| Bedding Products | $373.8M | 40% |
| Flooring And Textile Products Group | $196.9M | 21% |
| Automotive Group | $194.9M | 21% |
| Work Furniture Group | $66.2M | 7% |
| Home Furniture Group | $61.0M | 6% |
| Hydraulic Cylinders | $45.8M | 5% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |